Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Most cases of hypertension are because of essential hypertension, however 5% - 15% of cases can be a result of a secondary cause. In this article, we focus on the endocrine causes of secondary hypertension with a particular focus on pheochromocytomas (PCCs) and paragangliomas (PGLs). Around 15 endocrine disorders can initially present with hypertension. Amongst those PCCs and PGLs are rare but potentially life-threatening causes. An early diagnosis and timely referral can be life-saving. Herein, we present an approach for screening and diagnosis of these patients and focus on the importance of genetic testing.

More information Original publication

DOI

10.4102/safp.v63i1.5277

Type

Journal article

Publication Date

2021-07-14T00:00:00+00:00

Volume

63

Pages

e1 - e6

Keywords

endocrine, metanephrines, normetanephrines, paraganglioma, pheochromocytoma, screening, secondary hypertension, succinate dehydrogenase, Adrenal Gland Neoplasms, Genetic Testing, Humans, Hypertension, Paraganglioma, Pheochromocytoma